세계의 테라노스틱스 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)
Global Theranostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
상품코드:1820635
리서치사:Value Market Research
발행일:2025년 07월
페이지 정보:영문 132 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 테라노스틱스 시장은 크게 성장하고 있으며, 2024년 29억 8,000만 달러에서 2033년에는 97억 8,000만 달러에 이를 전망입니다. 2025-2033년 연평균 성장률(CAGR)은 14.11%로 성장할 것으로 예측됩니다.
세계의 테라노스틱스 시장은 진단 검사 및 표적 치료를 조합한 맞춤형 의료의 진보에 의해 급성장을 이룰 것으로 예측됩니다. 분자 이미징, 바이오마커 식별 및 동반 진단의 혁신으로 정확한 환자 계층화 및 치료 모니터링이 가능해지고 있습니다. 향후 개발은 AI와 머신러닝을 통합하여 예측 정확도를 높이고 치료 결과를 최적화하는 데 중점을 둡니다.
또한, 암 및 신경 질환과 같은 만성질환의 유병률 증가는 테라노스틱스 솔루션 수요를 확대하고 있습니다. 규제 당국의 지원과 연구개발 투자 확대는 시장 도입을 가속화하고 있습니다. 유전체학, 단백질체학, 나노기술의 융합은 새로운 테라노스틱스 치료제를 키우고 있습니다. 헬스케어가 정밀의료로 전환하는 가운데, 테라노스틱스 시장은 앞으로도 혁신을 계속해, 주문제작으로 효과적이고 비용 효율적인 헬스케어 솔루션을 제공해 나갈 것입니다.
목차
제1장 서문
제2장 주요 요약
시장의 하이라이트
세계 시장 현황
제3장 테라노스틱스 : 산업 분석
서문 : 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
업계 동향
Porter's Five Forces 분석
시장 매력 분석
제4장 밸류체인 분석
밸류체인 분석
원재료 분석
원재료 리스트
원재료 제조업체 리스트
주요 원재료의 가격 동향
잠재적 구매자 목록
마케팅 채널
직접 마케팅
간접 마케팅
마케팅 채널 발전 동향
제5장 세계의 테라노스틱스 시장 분석 : 제품별
개요 : 제품별
과거 및 예측 데이터 분석 : 제품별
화상 진단
방사성의약품
IVD 및 바이오마커 탐색
소프트웨어 및 서비스
제6장 세계의 테라노스틱스 시장 분석 : 용도별
개요 : 용도별
과거 및 예측 데이터 분석 : 용도별
전립선암
골전이
신경 내분비 종양
림프종
심혈관 질환
기타
제7장 세계의 테라노스틱스 시장 분석 : 최종 용도별
개요 : 최종 용도별
과거 및 예측 데이터 분석 : 최종 용도별
병원
진단센터
전문 클리닉
기타
제8장 세계의 테라노스틱스 시장 분석 : 지역별
지역별 전망
서문
북미의 매출 분석
개요, 분석 및 예측
북미 : 부문별
북미 국가별
미국
캐나다
멕시코
유럽의 매출 분석
개요, 분석 및 예측
유럽 : 부문별
유럽 국가별
영국
프랑스
독일
이탈리아
러시아
기타 유럽
아시아태평양의 매출 분석
개요, 분석 및 예측
아시아태평양 : 부문별
아시아태평양 국가별
중국
인도
일본
한국
호주
동남아시아
기타 아시아태평양
라틴아메리카의 매출 분석
개요, 분석 및 예측
라틴아메리카 : 부문별
라틴아메리카 국가별
브라질
아르헨티나
페루
칠레
기타 라틴아메리카
중동 및 아프리카의 매출 분석
개요, 분석 및 예측
중동 및 아프리카 : 부문별
중동 및 아프리카 국가별 일람
사우디아라비아
아랍에미리트(UAE)
이스라엘
남아프리카
기타 중동 및 아프리카
제9장 테라노스틱스 기업 경쟁 구도
테라노스틱스 시장의 경쟁
제휴, 협력 및 협정
합병 및 인수
신제품 출시
기타 개발
제10장 기업 프로파일
주요 기업의 시장 점유율 분석
시장 집중도
Bayer AG
Beckman Coulter Inc.
Cardinal Health Inc.
Canon Medical Systems Corporation
Curium
F. Hoffmann La Roche Ltd.
GE HealthCare Technologies Inc.
Koninklijke Philips NV
Lantheus Holdings Inc.
Siemens Healthnieers AG
Thermo Fisher Scientific Inc
AJY
영문 목차
영문목차
Global Theranostics Market is poised to witness substantial growth, reaching a value of USD 9.78 Billion by the year 2033, up from USD 2.98 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 14.11% between 2025 and 2033.
The global theranostics market is poised for rapid growth driven by advancements in personalized medicine that combine diagnostic testing with targeted therapy. Innovations in molecular imaging, biomarker identification, and companion diagnostics are enabling precise patient stratification and treatment monitoring. Future developments will focus on integrating AI and machine learning to enhance predictive accuracy and optimize therapeutic outcomes.
Moreover, increasing prevalence of chronic diseases such as cancer and neurological disorders is expanding demand for theranostic solutions. Regulatory support and growing investments in R&D are accelerating market adoption. The convergence of genomics, proteomics, and nanotechnology is fostering novel theranostic agents. As healthcare shifts towards precision medicine, the theranostics market will continue to innovate, delivering tailored, effective, and cost-efficient healthcare solutions.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
LIST OF SEGMENTS COVERED
This section of the Theranostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
Diagnostic Imaging
Radiopharmaceuticals
IVD/Biomarker Screeening
Software And Services
By Application
Prostate Cancer
Bone Metastasis
Neuroendocrine Tumors
Lymphoma
Cardiovascular Diseases
Other
By End-Use
Hospitals
Diagnostics Centers
Specialty Clinics
Other
List of Companies Profiled in the report
Bayer AG, Beckman Coulter Inc., Cardinal Health Inc., Canon Medical Systems Corporation, Curium, F. Hoffmann La Roche Ltd., GE HealthCare Technologies Inc., Koninklijke Philips N.V., Lantheus Holdings Inc., Siemens Healthnieers AG, Thermo Fisher Scientific Inc.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-Use
3.7.4 Market Attractiveness Analysis By Regions
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL THERANOSTICS MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Diagnostic Imaging Historic and Forecast Sales By Regions
5.4. Radiopharmaceuticals Historic and Forecast Sales By Regions
5.5. Ivd/Biomarker Screeening Historic and Forecast Sales By Regions
5.6. Software And Services Historic and Forecast Sales By Regions
6. GLOBAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Prostate Cancer Historic and Forecast Sales By Regions
6.4. Bone Metastasis Historic and Forecast Sales By Regions
6.5. Neuroendocrine Tumors Historic and Forecast Sales By Regions
6.6. Lymphoma Historic and Forecast Sales By Regions
6.7. Cardiovascular Diseases Historic and Forecast Sales By Regions
6.8. Other Historic and Forecast Sales By Regions
7. GLOBAL THERANOSTICS MARKET ANALYSIS BY END-USE
7.1. Overview By End-Use
7.2. Historical and Forecast Data Analysis By End-Use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Diagnostics Centers Historic and Forecast Sales By Regions
7.5. Specialty Clinics Historic and Forecast Sales By Regions
7.6. Other Historic and Forecast Sales By Regions
8. GLOBAL THERANOSTICS MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE THERANOSTICS COMPANIES
9.1. Theranostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF THERANOSTICS INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Bayer AG
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Beckman Coulter Inc.
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. Cardinal Health Inc.
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. Canon Medical Systems Corporation
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. Curium
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. F. Hoffmann La Roche Ltd.
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. GE HealthCare Technologies Inc.
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. Koninklijke Philips N.V.
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
10.11. Lantheus Holdings Inc.
10.11.1 Company Overview
10.11.2 Company Revenue
10.11.3 Products
10.11.4 Recent Developments
10.12. Siemens Healthnieers AG
10.12.1 Company Overview
10.12.2 Company Revenue
10.12.3 Products
10.12.4 Recent Developments
10.13. Thermo Fisher Scientific Inc
10.13.1 Company Overview
10.13.2 Company Revenue
10.13.3 Products
10.13.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies
